133
Views
13
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection

, , , , , , , , , , & show all
Pages 243-249 | Received 15 Sep 2009, Accepted 27 Oct 2009, Published online: 23 Jan 2010

References

  • Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008;100:1134–43.
  • Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002;36:1408–15.
  • Fujiwara A, Sakaguchi K, Fujioka S, Iwasaki Y, Senoh T, Nishimura M, Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels. J Gastroenterol 2008;43:484–91.
  • Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.
  • Ohata K, Hamasaki K, Toriyama K, Ishikawa H, Nakao K, Eguchi K. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2004;19:670–5.
  • Wu CF, Yu MW, Lin CL, Liu CJ, Shih WL, Tsai KS, Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis 2008;29:106–12.
  • Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol 2009;50:80–8.
  • Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007;46:912–21.
  • Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002;122:1609–19.
  • Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 2006;193:1258–65.
  • Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039–47.
  • Mahmood S, Niiyama G, Kamei A, Izumi A, Nakata K, Ikeda H, Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma. Liver Int 2005;25:220–5.
  • Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003;37:19–26.
  • Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127:S35–50.
  • Park BK, Park YN, Ahn SH, Lee KS, Chon CY, Moon YM, Long-term outcome of chronic hepatitis B based on histological grade and stage. J Gastroenterol Hepatol 2007;22:383–8.
  • Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991;13:398–406.
  • McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001;135:759–68.
  • Tang B, Kruger WD, Chen G, Shen F, Lin WY, Mboup S, Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers. J Med Virol 2004;72:35–40.
  • Ishikawa T, Ichida T, Yamagiwa S, Sugahara S, Uehara K, Okoshi S, High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis. J Gastroenterol Hepatol 2001;16:1274–81.
  • Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007;22:1104–11.
  • Murata K, Sugimoto K, Shiraki K, Nakano T. Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection. World J Gastroenterol 2005;11:6848–52.
  • Karasu Z, Tekin F, Ersoz G, Gunsar F, Batur Y, Ilter T, Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci 2007;52:1535–9.
  • Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 2005;11:1167–9.
  • Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009;136:138–48.
  • Ma H, Wei L, Guo F, Zhu S, Sun Y, Wang H. Clinical features and survival in Chinese patients with hepatitis B e antigen-negative hepatitis B virus-related cirrhosis. J Gastroenterol Hepatol 2008;23:1250–8.
  • Ikeda K, Arase Y, Kobayashi M, Someya T, Hosaka T, Saitoh S, Hepatitis B virus-related hepatocellular carcinogenesis and its prevention. Intervirology 2005;48:29–38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.